Label Changes for:

Keppra (levetiracetam) Tablets, XR tablets, Oral Solution, Injection

July 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

July 2013

ADVERSE REACTIONS

Postmarketing Experience
  • choreoathetosis and dyskinesia
     
Hide
(web4)